SG11201502693SA - Nmr quantification of branched chain amino acids - Google Patents
Nmr quantification of branched chain amino acidsInfo
- Publication number
- SG11201502693SA SG11201502693SA SG11201502693SA SG11201502693SA SG11201502693SA SG 11201502693S A SG11201502693S A SG 11201502693SA SG 11201502693S A SG11201502693S A SG 11201502693SA SG 11201502693S A SG11201502693S A SG 11201502693SA SG 11201502693S A SG11201502693S A SG 11201502693SA
- Authority
- SG
- Singapore
- Prior art keywords
- amino acids
- branched chain
- chain amino
- nmr quantification
- quantification
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/4625—Processing of acquired signals, e.g. elimination of phase errors, baseline fitting, chemometric analysis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- High Energy & Nuclear Physics (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261711471P | 2012-10-09 | 2012-10-09 | |
US13/801,604 US9535144B2 (en) | 2012-06-01 | 2013-03-13 | NMR quantification of TMAO |
US13/830,199 US9470771B2 (en) | 2012-06-08 | 2013-03-14 | NMR measurements of NMR biomarker GlycA |
US13/830,784 US9361429B2 (en) | 2012-06-08 | 2013-03-14 | Multi-parameter diabetes risk evaluations |
PCT/US2013/041274 WO2013180961A1 (en) | 2012-06-01 | 2013-05-16 | Nmr quantification of tmao |
PCT/US2013/043343 WO2013184483A1 (en) | 2012-06-08 | 2013-05-30 | Nmr measurements of glyca |
US201361831353P | 2013-06-05 | 2013-06-05 | |
PCT/US2013/044679 WO2013185014A1 (en) | 2012-06-08 | 2013-06-07 | Multi-parameter diabetes risk evaluations |
PCT/US2013/064142 WO2014059025A1 (en) | 2012-10-09 | 2013-10-09 | Nmr quantification of branched chain amino acids |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201502693SA true SG11201502693SA (en) | 2015-05-28 |
Family
ID=50477859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201502693SA SG11201502693SA (en) | 2012-10-09 | 2013-10-09 | Nmr quantification of branched chain amino acids |
Country Status (7)
Country | Link |
---|---|
EP (2) | EP2906956B1 (en) |
JP (1) | JP6268181B2 (en) |
CN (1) | CN104823055B (en) |
AU (1) | AU2013329308B2 (en) |
CA (1) | CA2887475C (en) |
SG (1) | SG11201502693SA (en) |
WO (1) | WO2014059025A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9470771B2 (en) | 2012-06-08 | 2016-10-18 | Liposcience, Inc. | NMR measurements of NMR biomarker GlycA |
US9361429B2 (en) | 2012-06-08 | 2016-06-07 | Liposcience, Inc. | Multi-parameter diabetes risk evaluations |
US9928345B2 (en) | 2012-06-08 | 2018-03-27 | Liposciences, Inc. | Multiple-marker risk parameters predictive of conversion to diabetes |
AU2014227653B2 (en) | 2013-03-15 | 2017-04-20 | The General Hospital Corporation | Using RNA-guided foki nucleases (RFNs) to increase specificity for RNA-guided genome editing |
JP6834488B2 (en) * | 2014-10-08 | 2021-02-24 | 味の素株式会社 | Acquisition method, evaluation device, evaluation program and evaluation system |
US9926546B2 (en) | 2015-08-28 | 2018-03-27 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
AU2017380103B2 (en) * | 2016-12-22 | 2020-07-02 | Numares Ag | Method for determining proper functioning of an analytic system and control composition for performing said method |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0698036B2 (en) | 1986-10-20 | 1994-12-07 | 小野薬品工業株式会社 | Selective quantification of amino acids |
US4933844A (en) | 1988-09-26 | 1990-06-12 | Otvos James D | Measurement of blood lipoprotein constituents by analysis of data acquired from an NMR spectrometer |
US5146166A (en) | 1990-08-06 | 1992-09-08 | Chemagnetics, Inc. | Method and apparatus for enhancing sample analysis rate in magnetic resonance spectroscopy |
US6617167B2 (en) | 2001-08-01 | 2003-09-09 | Liposcience, Inc. | Method of determining presence and concentration of lipoprotein X in blood plasma and serum |
WO2004040407A2 (en) | 2002-10-25 | 2004-05-13 | Liposcience, Inc. | Methods, systems and computer programs for deconvolving the spectral contribution of chemical constituents with overlapping signals |
US6768305B1 (en) | 2003-09-26 | 2004-07-27 | Varian, Inc. | Temperature controlled sample changer for NMR analysis |
CA2561536C (en) | 2004-04-01 | 2017-09-19 | Liposcience, Inc. | Nmr clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples |
JP5006524B2 (en) * | 2005-05-13 | 2012-08-22 | 株式会社日立製作所 | Signal processing method of NMR apparatus for specifying relaxation time |
JP4358814B2 (en) * | 2005-11-09 | 2009-11-04 | 花王株式会社 | Sample analysis method |
US7923257B2 (en) | 2007-05-04 | 2011-04-12 | Perkinelmer Health Sciences, Inc. | Detecting isomers using differential derivatization mass spectrometry |
EP2019311A1 (en) * | 2007-07-23 | 2009-01-28 | F.Hoffmann-La Roche Ag | A method for detecting a target substance by nuclear magnetic resonance |
WO2009064843A1 (en) | 2007-11-13 | 2009-05-22 | Bayer Healthcare Llc | Method to measure amino acid concentrations |
WO2010002479A1 (en) | 2008-07-03 | 2010-01-07 | Lowery Thomas Jay Jr | Magnetic nanosensor compositions and bioanalytical assays therefor |
ES2799327T3 (en) * | 2009-05-05 | 2020-12-16 | Infandx Ag | Method to diagnose suffocation |
EP3100610A1 (en) | 2009-07-24 | 2016-12-07 | Baylor College Of Medicine | Methods of modulation of branched chain acids and uses thereof |
EP2572193B1 (en) * | 2010-05-21 | 2017-11-01 | The Governors Of The University Of Alberta | Methods for the assessment of colorectal cancer and colorectal polyps by measurement of metabolites in urine |
-
2013
- 2013-10-09 CN CN201380064302.9A patent/CN104823055B/en active Active
- 2013-10-09 AU AU2013329308A patent/AU2013329308B2/en active Active
- 2013-10-09 JP JP2015536865A patent/JP6268181B2/en active Active
- 2013-10-09 SG SG11201502693SA patent/SG11201502693SA/en unknown
- 2013-10-09 WO PCT/US2013/064142 patent/WO2014059025A1/en active Application Filing
- 2013-10-09 CA CA2887475A patent/CA2887475C/en active Active
- 2013-10-09 EP EP13844778.4A patent/EP2906956B1/en not_active Revoked
- 2013-10-09 EP EP20199972.9A patent/EP3842818A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2013329308A1 (en) | 2015-04-30 |
JP2015537197A (en) | 2015-12-24 |
CA2887475C (en) | 2021-12-14 |
EP3842818A1 (en) | 2021-06-30 |
JP6268181B2 (en) | 2018-01-24 |
WO2014059025A1 (en) | 2014-04-17 |
AU2013329308B2 (en) | 2018-11-01 |
EP2906956A4 (en) | 2016-06-29 |
EP2906956A1 (en) | 2015-08-19 |
CN104823055A (en) | 2015-08-05 |
CN104823055B (en) | 2017-12-05 |
CA2887475A1 (en) | 2014-04-17 |
EP2906956B1 (en) | 2020-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1211569A1 (en) | Amino acid derivatives | |
HK1207156A1 (en) | Nmr measurements of glyca glyca | |
HK1210172A1 (en) | Crystal of dispiropyrrolidine derivative | |
DK2890402T3 (en) | MODIFIED AMINO ACIDS INCLUDING AN AZIDOG GROUP | |
HK1210144A1 (en) | New indanyloxydihydrobenzofuranylacetic acids | |
EP2788507A4 (en) | Method of measuring immune activation | |
IL234914A (en) | Quantification of impurities for release testing of peptide products | |
ZA201407034B (en) | Phenyl alkanoic acid derivatives as gpr agonists | |
PL2563850T3 (en) | Expansible beads of polyamide | |
EP2750681A4 (en) | Branched discrette peg constructs | |
SG11201502693SA (en) | Nmr quantification of branched chain amino acids | |
EP2813487A4 (en) | Basic amino acid derivative | |
EP2804488A4 (en) | Method of instantizing amino acids | |
EP2861655A4 (en) | Methods for desolventization of bagasse | |
IL235556B (en) | Enzymatic synthesis of l-nucleic acids | |
EP2726849A4 (en) | Measurement of critical dimension | |
BR112013033734A2 (en) | branched polyamide with different blocks | |
GB201208293D0 (en) | Hydrochlorice salt of peptide | |
BR112013033512A2 (en) | branched polyamide | |
EP2859338A4 (en) | Nmr quantification of tmao | |
EP2726652A4 (en) | Method of protein display | |
EP2681188A4 (en) | Amidation process | |
HK1200458A1 (en) | Methods of isolating 4-chloro-2-fluoro-3-substituted-phenylboronic acids 4--2--3-- | |
EP2909226A4 (en) | Derivatives of collagen-binding hairpin peptides | |
EP3560952C0 (en) | Variant of bpifb4 protein |